**Summary of Spectris PLC Half-Year Report (H1 2025)**
**Financial Performance Highlights**
**Revenue Growth** Reported sales increased by 8% to £636.1 million (1% LFL growth), with strong momentum in Q2 (20% reported, 9% LFL).
**Order Growth** Reported orders grew by 5% (-2% LFL), with Q2 showing 15% growth (4% LFL).
**Profitability** Adjusted operating profit rose to £65.6 million (up 7% reported, flat LFL), with statutory operating profit at £24.8 million (up 3%).
**Cost Savings** Realized over £10 million in H1 from the Profit Improvement Programme, with £30 million expected for the full year.
**Net Debt** Net debt stood at £546 million, with leverage expected to return to the 1-2x target range by year-end.
**Strategic Developments**
**Acquisition Integration** Successful integration of SciAps, Micromeritics, and Piezocryst, with expected full-year incremental profit contributions unchanged.
**Profit Improvement Programme** On track to deliver £30 million in savings in 2025, with two-thirds realized in H2.
**R&D Investment** £50.2 million invested in H1, supporting innovation and future growth.
**Divisional Performance**
**Spectris Scientific** Sales up 21% reported (3% LFL), driven by strong growth in academia, life sciences, and materials. Adjusted operating margin improved to 11.1%.
**Spectris Dynamics** Sales flat reported (-3% LFL), with automotive weakness offset by growth in machine manufacturing. Adjusted operating margin at 12.4%.
**Corporate Developments**
**KKR Acquisition Offer** The Board recommended KKRs acquisition offer of £41.75 per share (inclusive of a 28.0p interim dividend), pending shareholder and regulatory approvals.
**Dividend Increase** Interim dividend raised by 5% to 28.0p per share.
**Outlook**
Full-year adjusted operating profit expected to align with management expectations, supported by improving sales, acquisitions, and efficiency programs.
Leverage reduction and continued focus on strategic investments and operational excellence.
**Key Metrics**
Adjusted EPS38.4p (down 20% due to higher net finance charges).
Cash Conversion126% (up from 111% in H1 2024).
ROGCE12.2% (down from 16.8% in H1 2024).
**Conclusion**
Spectris PLC demonstrated resilience in H1 2025, with strong topline growth, cost discipline, and strategic progress. The KKR acquisition offer underscores the companys value, while its focus on innovation and efficiency positions it for sustained success in precision measurement markets.